Home / BusinessBusinessBloombergBusinessBloomberg·Sep 8, 2026·1 min readEuropean Stocks Muted as Novartis Shares Fall Most on RecordEuropean stocks were steady on Tuesday, with heavyweight Novartis AG weighing on the market after suffering its third clinical-trial setback in a week.View original source — Bloomberg ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessBloombergBusinessSep 7, 2026 · 1 minEuropean Stocks Muted as Oil Prices Climb and Novartis FallsBloombergBusinessCNBCBusinessSep 8, 2026 · 1 minPharma major plummets over 10% after third trial disappointment in a weekCNBCBusinessBloombergBusinessSep 3, 2026 · 1 minEuropean Stocks Muted as Deutsche Telekom Gains on Elliott StakeBloombergBusinessBloombergBusinessSep 8, 2026 · 1 minNovartis and Boston Scientific Slide, Intel Price Hikes | Stock MoversBloomberg
BusinessBloombergBusinessSep 7, 2026 · 1 minEuropean Stocks Muted as Oil Prices Climb and Novartis FallsBloomberg
BusinessCNBCBusinessSep 8, 2026 · 1 minPharma major plummets over 10% after third trial disappointment in a weekCNBC
BusinessBloombergBusinessSep 3, 2026 · 1 minEuropean Stocks Muted as Deutsche Telekom Gains on Elliott StakeBloomberg
BusinessBloombergBusinessSep 8, 2026 · 1 minNovartis and Boston Scientific Slide, Intel Price Hikes | Stock MoversBloomberg